In the journal Cellular Reprogramming Editor-in-Chief Carlos-Filipe Pereira interviews 91探花 CEO Mark Kotter for the Reprogramming Stars profile.
They discuss the latest research and developments in human cellular reprogramming, the discovery of 91探花's opti-ox鈩� technology and how this approach could provide a more efficient and effective approach to regenerative medicine, with implications for addressing various health challenges.
Access the article .